Learn / Epidemiology / Chronic disease, cancer, and maternal and child health
Cancer epidemiology
13 minute read · 6-question quiz
What you will learn
Define cancer incidence, mortality, survival and the mortality-to-incidence ratio
Explain the role of cancer registries and what they can and cannot tell us
Describe the major preventable causes and the cancers of importance in Uganda
Cancer is not one disease but hundreds, each with its own causes, natural history and treatment. Epidemiology describes how many people are affected, who, where and why, and tells us which cancers can be prevented or detected early.
Core measures
- Incidence: new cases per 100,000 per year, usually age-standardised (ASR) to compare populations.
- Mortality: deaths per 100,000 per year.
- Prevalence: people alive with a past cancer diagnosis (survivors), important for planning services.
- Survival: the proportion alive at 1, 3 or 5 years after diagnosis. Net survival removes deaths from other causes and is used to compare countries.
- Mortality-to-incidence ratio (M:I): deaths ÷ new cases in the same year; a crude marker of survival where registry survival data are missing. A ratio near 0.2 suggests high survival (many cancers in high-income countries); 0.5 or more suggests poor survival.
Cancer registries
Hospital-based registry
Records patients at one hospital; good for clinical care, but cannot give population rates.
Population-based registry
Records all new cases in a defined geographic population; gives true incidence rates. In Uganda the Kampala Cancer Registry, established in 1951, is one of the oldest in Africa.
Data sources
Pathology laboratories, hospitals, death certificates, with active case-finding.
Quality indicators
Completeness, percentage microscopically verified, percentage 'death certificate only', and timeliness.
Causes and prevention
An estimated 30 to 50% of cancers are preventable by avoiding risk factors and applying existing evidence. Infection-related cancers make up a higher share in Africa than in high-income regions.
| Cause | Examples | Prevention |
| Tobacco | Lung, mouth, bladder | Taxes, bans, cessation support |
| Infections | HPV (cervical), hepatitis B and C (liver), H. pylori (stomach), HIV with HHV-8 (Kaposi sarcoma), EBV (Burkitt lymphoma) | HPV and hepatitis B vaccination, treatment, safe injections |
| Alcohol | Liver, oesophagus, breast | Regulation |
| Diet and obesity | Colorectal, breast, endometrial | Healthy diet, activity |
| Occupation and environment | Asbestos, aflatoxin, air pollution | Regulation, food safety |
| Ultraviolet radiation | Skin cancers (high risk in people with albinism) | Sun protection |
In Uganda, commonly diagnosed cancers include cervical cancer, Kaposi sarcoma, breast, prostate, oesophageal and liver cancers and non-Hodgkin lymphoma. Late presentation is a major reason for poor survival: many patients arrive at advanced stage because of costs, distance and limited diagnostic and treatment capacity.
Summary
Use age-standardised incidence and mortality, plus net survival, for comparisons.
Population-based registries give true incidence; hospital registries do not.
M:I ratio is a crude indicator of survival.
Many cancers in Africa are infection-related and preventable by vaccination and treatment.
Survival differences reflect stage, treatment access, lead time and data quality.
Check your understanding
Draft study guide. Spotted an error or something unclear? Tell us at hello@scintria.com. This is educational material, not clinical or regulatory advice.